CureDuchenne Ventures is the venture philanthropy arm of CureDuchenne, based in Newport Beach, California, and focused on accelerating treatments for Duchenne muscular dystrophy and related neuromuscular conditions. It invests strategically to move promising science closer to clinical impact.

The fund has supported a wide range of projects and companies and is notable for recycling financial returns back into research and patient programs. Its model combines mission orientation with investment discipline, making it especially relevant for founders working in disease-specific therapeutic and enabling technology areas.

Its activity is concentrated in North America, with some exposure to European biotech hubs. While not broad neurotech investor, it is highly relevant for neuromuscular and neuro-related health technologies with translational clinical potential.